Search

Your search keyword '"Cervarix (Vaccine)"' showing total 50 results
Start Over Descriptor "Cervarix (Vaccine)" Topic health
50 results on '"Cervarix (Vaccine)"'

1. Human papillomavirus vaccines: WHO position paper (2022 update)/ Vaccins contre les papillomavirus humains: note de synthese de l'OMS (mise a jour de 2022)

Subjects
Vaccination, Medical policy, Papillomavirus infections, Vaccines, Government, Health, World Health Organization, Cervarix (Vaccine)
Abstract

Introduction In accordance with its mandate to provide normative guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers (1) on vaccines and [...]

Published
2022

2. Human papillomavirus vaccines: WHO position paper, May 2017/ Vaccins contre les papillomavirus humains: note de synthese de l'OMS, mai 2017

Subjects
Vaccines, Papillomavirus infections -- Development and progression, Health policy, Government, Health, World Health Organization, Cervarix (Vaccine)
Abstract

Introduction In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and vaccine combinations [...]

Published
2017

3. Study Findings on Human Papillomavirus 16 Described by Researchers at Ragon Institute [Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination]

Subjects
Merck & Company Inc., Vaccination -- Analysis, Medical research -- Analysis, Medicine, Experimental -- Analysis, Papillomaviruses -- Analysis, Cervical cancer -- Analysis, Pharmaceutical industry -- Analysis, Health, Cervarix (Vaccine)
Abstract

2023 APR 5 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators discuss new findings in human papillomavirus 16. According to news reporting from the Ragon [...]

Published
2023

4. HPV vax unmasks cervical lesions from non-vax strains

Author

Otto, M. Alexander

Subjects
Merck & Company Inc., Vaccination, Papillomavirus infections, Vaccines, Pharmaceutical industry, Health, Health care industry, Cervarix (Vaccine)
Abstract

Vaccines against human papillomavirus have been hailed as a success: They have been shown to decrease the incidence of cervical lesions associated with the HPV types that are in the [...]

Published
2022

5. Global Advisory Committee on Vaccine Safety, 11-12 December 2013/Comite consultatif mondial de la Securite vaccinale, 11-12 decembre 2013

Subjects
Australia. Therapeutic Goods Administration -- Safety and security measures, Vaccination, Influenza vaccines, Papillomavirus infections, Influenza, Government, Health, Cervarix (Vaccine), Rota Teq (Vaccine), Rotarix (Vaccine)
Abstract

The Global Advisory Committee on Vaccine Safety (GACVS), an expert clinical and scientific advisory body, was established by WHO to provide independent, scientifically rigorous advice on vaccine safety issues of [...]

Published
2014

6. HPV Vaccination When Young Cuts Cervical Cancer Risk by 87%

Subjects
Oncology, Experimental, Vaccination, Cancer -- Prevention -- Research, Cervical cancer -- Risk factors, Health, Cervarix (Vaccine)
Abstract

THURSDAY, Nov. 4, 2021 (HealthDay News) -- The sooner girls are vaccinated against human papillomavirus (HPV), the lower their future risk of cervical cancer, a new study finds. Compared to [...]

Published
2021

7. Human Papillomavirus HPV Vaccines Disease Analysis Report 2021 - ResearchAndMarkets.com

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination -- Forecasts and trends, Papillomaviruses -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccines -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Pharmaceuticals and cosmetics industries, Health, Cervarix (Vaccine)
Abstract

2021 JUL 19 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. [...]

Published
2021

8. The human papillomavirus (HPV): lost in space

Author

Rochon, Donna

Subjects
Cervarix (Vaccine), Vaccination, Sexually transmitted diseases -- Prevention, Papillomaviruses -- Prevention, Papillomavirus infections -- Prevention, Vaccines, Warts -- Prevention, Health, Diseases, Prevention
Abstract

If there were a vaccine available that could prevent an infectious disease, wouldn't you jump at the chance to be vaccinated? No, not for H IV infection--although this disease is [...]

Published
2007

9. Findings from University of Ferrara Provide New Insights into Vaccination (HPV-Specific Systemic Antibody Responses and Memory B Cells are Independently Maintained up to 6 Years and in a Vaccine-Specific Manner Following Immunization with ...)

Subjects
Cervical cancer -- Research, B cells, Vaccination, Papillomavirus, Infection, Characterization, Tumors, Public health, Editors, Diseases, Public health movements, Health, Cervarix (Vaccine)
Abstract

2020 FEB 5 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators publish new report on Public Health - Vaccination. According to news reporting originating in [...]

Published
2020

10. New Findings from Zagazig University Yields New Data on Human Papillomavirus Vaccines (Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts)

Subjects
Antigens, Vaccines -- Research, Papillomavirus -- Research -- Care and treatment, Papillomavirus infections -- Research -- Care and treatment, Medical research, Infection, Public health, Editors, Health, Cervarix (Vaccine)
Abstract

2019 AUG 7 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Current study results on Immunization and Public Health - Human Papillomavirus Vaccines have been published. [...]

Published
2019

11. Study Data from Public Health England Provide New Insights into Human Papillomavirus Vaccines [Durability of the Neutralizing Antibody Response To Vaccine and Non-vaccine Hpv Types 7 Years Following Immunization With Either Cervarix ® or ...]

Subjects
Vaccines -- Research, Papillomavirus -- Research, Public health, Biopharmaceuticals -- Research, Genotypes, Editors, Health, Cervarix (Vaccine)
Abstract

2019 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Data detailed on Immunization and Public Health - Human Papillomavirus Vaccines have been presented. According [...]

Published
2019

12. Pharmacology Update: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Cervarix™)

Subjects
Vaccines, Antigens, Medical research, Medicine, Experimental, Papillomavirus infections, Pharmacology, Papillomaviruses, Health, Cervarix (Vaccine)
Abstract

Pharmacology Update Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Cervarix.sup.™) By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD. Dr. Elliott is Chair, Formulary Committee, Northern [...]

Published
2010

13. Gardasil approved for use in males u Cervarix gets OK for use in females

Subjects
Merck & Company Inc., Warts -- Prevention, Papillomavirus infections -- Prevention, Cervical cancer -- Prevention, Cancer -- Care and treatment, Pharmaceutical industry, Cancer vaccines, Health, Cervarix (Vaccine)
Abstract

Gardasil approved for use in males -- Cervarix gets OK for use in females Both recommended for Vaccines for Children coverage Two new actions from the Food and Drug Administration [...]

Published
2009

14. Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Cervarix™)

Subjects
Vaccines, Antigens, Medical research, Medicine, Experimental, Papillomavirus infections, Papillomaviruses, Health, Cervarix (Vaccine)
Abstract

Pharmacology Update Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Cervarix.sup.™) By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD. Dr. Elliott is Chair, Formulary Committee, Northern [...]

Published
2009

15. HPV vaccine update: Will there be more options for women and men?

Subjects
Merck & Company Inc., Papillomavirus infections -- Prevention, Cervical cancer -- Prevention, Cancer -- Care and treatment, Pharmaceutical industry, Cancer vaccines, Health, Cervarix (Vaccine)
Abstract

HPV vaccine update: Will there be more options for women and men? FDA committee gives nod to Cervarix use in females, Gardasil in males Get set for possible changes in [...]

Published
2009

16. * Cervarix vaccine no longer supplied

Subjects
Merck & Company Inc., Vaccines, Papillomavirus infections -- Drug therapy, Pharmaceutical industry, Health, Cervarix (Vaccine)
Abstract

GlaxoSmithKline announced it will no longer be supplying Cervarix for use in the U.S. Cervarix is a vaccine indicated for the prevention of various diseases caused by oncogenic human papillomavirus [...]

Published
2016

17. HPV vaccine myths put health, lives at risk, say health leaders

Author

Tucker, Charlotte

Subjects
United States. Food and Drug Administration, United States. Centers for Disease Control and Prevention, Vaccination, Papillomavirus infections -- Prevention -- Drug therapy, Cervical cancer -- Prevention -- Drug therapy, Cancer vaccines, Health, Cervarix (Vaccine)
Abstract

Vaccination rates for human papillomavirus are lagging for teens, and a complicated web of confusion and misinformation may be to blame, according to public health leaders. Several strains of HPV [...]

Published
2011

18. Studies Conducted at Mazandaran University of Medical Sciences on Cervical Intraepithelial Neoplasia Recently Reported [Efficacy of Human Papillomavirus L1 Protein Vaccines (Cervarix and Gardasil) in Reducing the Risk of Cervical Intraepithelial ...]

Subjects
Vaccines -- Research, Papillomavirus -- Prevention -- Research, Papillomavirus infections -- Prevention -- Research, Vaccination, Cervix dysplasia -- Prevention -- Research, Health, Cervarix (Vaccine)
Abstract

2017 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Urogenital Diseases and Conditions - Cervical Intraepithelial Neoplasia have [...]

Published
2017

19. Findings on Vaccines Discussed by Investigators at National Institute of Allergy and Infectious Diseases (NIAID) (Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses)

Subjects
United States. National Institute of Allergy and Infectious Diseases, Positron emission tomography, Communicable diseases, Medical research, Vaccination, Health, Cervarix (Vaccine)
Abstract

2017 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Virus Weekly -- Investigators discuss new findings in Immunization - Vaccines. According to news reporting out of Bethesda, [...]

Published
2017

20. Vaccine guards against cancer of the cervix

Subjects
Biological products industry, Medical research, Medicine, Experimental, Papillomavirus infections -- Prevention, Cervical cancer -- Prevention, Cancer -- Prevention, Cancer vaccines, Health, Cervarix (Vaccine)
Abstract

Product: Cervarix Company: G1axoSmithKline Pharmacologic class: Vaccine (HYV) Active ingredient: Bivalent human papillomavirus (HYV) vaccine types 16 and 18 vaccine; recombinant; aluminum adsorbed; suspension for IM injection; preservative-free. Indication: In [...]

Published
2010

21. One and two doses of HPV-16/18 vaccine as effective as three

Subjects
Vaccines -- Analysis, Papillomavirus infections -- Analysis, Health, Cervarix (Vaccine)
Abstract

ONE OR TWO doses of the vaccine Cervarix may be as effective as the complete three-dose series against infections with high-risk human papillomavirus (HPV) types 16 and 18, according to [...]

Published
2015

22. FDA panel gives nod to second HPV vaccine

Author

MeChcatie, Elizabeth

Subjects
Merck & Company Inc., Cancer -- Prevention, Papillomavirus infections -- Prevention, Cervical cancer -- Prevention, Cancer vaccines, Pharmaceutical industry, Health, Cervarix (Vaccine)
Abstract

SILVER SPRING, MD.--The majority of a federal advisory panel agreed that the data on a recombinant bivalent human papillomavirus vaccine indicate that the vaccine is safe and effective in preventing [...]

Published
2009

23. New Human Papillomavirus Vaccines Findings from Lund University Described (Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines)

Subjects
HIV patients, AIDS vaccines -- Research, HIV -- Research, Medical research, Vaccination, Pharmaceuticals and cosmetics industries, Health, Science and technology, Lund University, Cervarix (Vaccine)
Abstract

2016 APR 18 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Current study results on Immunization and Public Health have been published. According to news [...]

Published
2016

24. Gardasil will replace Cervarix as the cervical cancer vaccination of choice

Subjects
Cervical cancer -- Prevention, Condyloma acuminatum -- Prevention, Health, Health care industry, Cervarix (Vaccine), Gardasil (Vaccine) -- Dosage and administration
Abstract

Gardasil will replace Cervarix as the cervical cancer vaccination of choice. Both vaccines protect against human papilloma virus types 16 and 18, which cause more than 70 per cent of [...]

Published
2011

25. Findings on Human Papillomavirus Reported by Investigators at Danish Health and Medicines Authority (Determination of freeze damage on HPV vaccines by use of flow cytometry)

Subjects
Vaccines -- Usage -- Research -- Analysis, Papillomavirus -- Research -- Analysis, Papillomavirus infections -- Research -- Analysis, Health, Cervarix (Vaccine)
Abstract

2015 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Current study results on Human Papillomavirus have been published. According to news reporting from Copenhagen, [...]

Published
2015

26. Single dose of HPV vaccine may prevent cervical cancer

Subjects
Vaccines, Cervical cancer -- Prevention, Papillomavirus infections -- Prevention, Cancer prevention, Pharmaceuticals and cosmetics industries, Health, Science and technology, Cervarix (Vaccine)
Abstract

2015 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- A single dose of the human papillomavirus (HPV) vaccine Cervarix appears to be as [...]

Published
2015

27. GlaxoSmithKline's Trademark Application for 'CERVARIX' Filed

Subjects
Vaccines, Trademarks, Pharmaceutical industry -- Intellectual property, Business, Pharmaceuticals and cosmetics industries, Health, Cervarix (Vaccine)
Abstract

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for 'CERVARIX' [...]

Published
2015

28. New Findings from GlaxoSmithKline Yields New Data on Cervical Cancer (Antibody avidity measurements in recipients of Cervarix vaccine following a two-dose schedule or a three-dose schedule)

Subjects
Medical research, Medicine, Experimental, Papillomavirus infections -- Research, Cervical cancer -- Research, Vaccines -- Research, Proteins, Health, Cervarix (Vaccine)
Abstract

By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators discuss new findings in Oncology. According to news reporting from Rixensart, Belgium, by NewsRx journalists, research stated, 'The HPV-16/18 [...]

Published
2014

29. Safety and immunogenicity of 2 doses of the HPV-16/18 AS04 adjuvanted vaccine Cervarix

Subjects
Papillomavirus infections -- Safety and security measures, Cervical cancer -- Safety and security measures, Vaccines -- Safety and security measures, Pharmaceuticals and cosmetics industries, Health, Science and technology, Cervarix (Vaccine)
Abstract

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- A recent study in the journal Human Vaccines & Immunotherapeutics, showed that two doses of the HPV-16/18 AS04-adjuvanted vaccine [...]

Published
2014

31. Gardasil, Cervarix: not interchangeable

Author

Pichichero, Michael E.

Subjects
Cancer -- Prevention, Papillomavirus infections, Cancer vaccines, Cervical cancer, Health, Health care industry, Cervarix (Vaccine)
Abstract

With the licensure of GlaxoSmithKline's human papillomavirus vaccine Cervarix in October, we will soon have two vaccines that prevent cervical cancer in women. But they're not interchangeable, and this could [...]

Published
2009

32. FDA approves Gardasil for boys and Cervarix for girls

Author

Farmer, Lori Buckner

Subjects
Merck & Company Inc., Papillomavirus infections, Drug approval, Pharmaceutical industry, Health, Health care industry, Cervarix (Vaccine)
Abstract

The Food and Drug Administration has approved the drug Gardasil for boys and men aged 926 years, and Cervarix for girls and women aged 10-25 years. Gardasil was approved for [...]

Published
2009

33. Second HPV vaccine for girls, women backed by panel

Author

Mechcatie, Elizabeth

Subjects
Papillomavirus infections -- Prevention, Cervical cancer -- Prevention, Cancer -- Prevention, Cancer vaccines, Health, Health care industry, Cervarix (Vaccine)
Abstract

SILVER SPRING, MD. -- The majority of a federal advisory panel agreed that the data on a recombinant bivalent human papillomavirus vaccine indicate that the vaccine is safe and effective [...]

Published
2009

34. Cervarix found more immunogenic than gardasil

Author

Tucker, Miriam E.

Subjects
Merck & Company Inc., Papillomavirus infections, Vaccines, Pharmaceutical industry, Health, Health care industry, Cervarix (Vaccine)
Abstract

ATLANTA -- The efficacy of GlaxoSmithKline's human papillomavirus vaccine against cervical intraepithelial neoplasia grade 2 or higher was confirmed in a final analysis of phase III data from more than [...]

Published
2009

35. Recent Findings from Health Protection Agency Provide New Insights into Vaccines

Subjects
Medical research, Medicine, Experimental, Papillomavirus infections -- Research, Vaccines -- Research, Health, Cervarix (Vaccine)
Abstract

By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators publish new report on Immunization. According to news reporting from London, United Kingdom, by NewsRx journalists, research stated, 'The [...]

Published
2013

36. Findings from International Agency for Research on Cancer Broaden Understanding of Vaccines

Subjects
Oncology, Experimental, Papillomavirus infections -- Research, Cancer -- Care and treatment -- Research, Vaccines -- Research, Health, Cervarix (Vaccine)
Abstract

By a News Reporter-Staff News Editor at Vaccine Weekly -- Current study results on Immunization have been published. According to news originating from Lyon, France, by NewsRx correspondents, research stated, [...]

Published
2013

37. Studies from National Cancer Institute Have Provided New Information about Vaccines

Subjects
United States. National Cancer Institute -- Analysis, Merck & Company Inc., Oncology, Experimental -- Analysis, Papillomavirus infections -- Analysis, Cancer -- Care and treatment -- Analysis -- Research, Cancer vaccines -- Analysis, Pharmaceutical industry -- Analysis, Health, Cervarix (Vaccine)
Abstract

By a News Reporter-Staff News Editor at Vaccine Weekly -- Research findings on Vaccines are discussed in a new report. According to news reporting originating from Bethesda, Maryland, by NewsRx [...]

Published
2013

38. Companies & Markets: Cancer Vaccines Market Set to Change

Subjects
Biological products industry, Cancer -- Care and treatment, Cancer vaccines, Pharmaceuticals and cosmetics industries, Health, Science and technology, Cervarix (Vaccine)
Abstract

The global cancer vaccines market was worth $3,483.0m in 2010, after increasing at a compound annual growth rate (CAGR) of 63.7% during 2006-2010. During 2010-2018, the market is expected to [...]

Published
2011

39. PULSE CLINICAL: What's new in Infectious disease

Subjects
Antiulcer drugs, Health, Health care industry, Cervarix (Vaccine)
Abstract

GP Dr Martin Wood on five key developments in H.pylori eradication, HIV testing, UTI treatment, and rotavirus and HPV vaccination 1 Quadruple therapy for H.pylori eradication Half of the population [...]

Published
2011

40. Fewer than 3 doses of cervical cancer vaccine effective

Subjects
Papillomavirus infections, Cancer -- Care and treatment, Cervical cancer, Cancer vaccines, Pharmaceuticals and cosmetics industries, Health, Science and technology, Cervarix (Vaccine)
Abstract

Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, [...]

Published
2011

41. HPV: Fewer doses of Cervarix are as effective as three

Subjects
Papillomavirus infections, Vaccines, Health, Health care industry, Cervarix (Vaccine)
Abstract

One or two doses of the HPV vaccine Cervarix may be as effective in protecting against persistent HPV infections as the standard three-dose regimen. US researchers looked at data from [...]

Published
2011

42. Study Findings on Cellular Immunology Are Outlined in Reports from University of Wollongong

Subjects
T cells -- Analysis, Papillomavirus infections -- Research -- Analysis, Vaccines -- Research -- Analysis, Universities and colleges -- Analysis, Health, Science and technology, University of Wollongong, Cervarix (Vaccine)
Abstract

'Chronic infection with certain types of human papillomaviruses (HPV), especially HPV-16 and HPV-18, leads to the development of cervical cancer. Prophylactic HPV vaccines based on HPV virus like particles (VLPs) [...]

Published
2011

43. Studies from Mayo Clinic yield new data on cervical cancer

Subjects
Oncology, Experimental, Cancer -- Prevention -- Research, Papillomavirus infections -- Prevention, Cervical cancer -- Prevention, Cancer vaccines, Health, Cervarix (Vaccine)
Abstract

'In October 2009, the Advisory Committee on Immunization Practices (ACIP) approved a newly licensed vaccine, Cervarix ®, directed against human papillomavirus (HPV) to prevent cervical cancer. The ACIP also expanded [...]

Published
2010

44. GSK European Commission amends licence for Cervarix

Subjects
Papillomavirus infections, Cancer -- Care and treatment, Cervical cancer, Cancer vaccines, Pharmaceutical industry, Pharmaceuticals and cosmetics industries, Health, Science and technology, European Union. European Commission, Cervarix (Vaccine)
Abstract

London UK - GlaxoSmithKline (GSK) confirmed that the European Commission has granted Marketing Authorisation to amend the licence for its cervical cancer vaccine, Cervarix® (see also Human Papillomavirus). The approval [...]

Published
2010

45. New cervical intraepithelial neoplasia study findings have been published by scientists at University of Missouri

Subjects
Medical research, Medicine, Experimental, Papillomavirus infections -- Research, Cervical cancer -- Research, Scientists, Cancer vaccines -- Research, Universities and colleges, Cervix dysplasia -- Research, Pharmaceuticals and cosmetics industries, Health, Science and technology, University of Missouri, Cervarix (Vaccine)
Abstract

According to recent research from the United States, 'Of review Studies of the human papillomavirus (HPV) vaccines, Cervarix and Gardasil provide strong evidence for the recommendation that HPV vaccines may [...]

Published
2010

46. CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women

Subjects
Cancer -- Prevention -- Care and treatment, Papillomavirus infections -- Prevention, Cervical cancer -- Prevention, Young women, Pharmaceuticals and cosmetics industries, Health, Science and technology, Cervarix (Vaccine)
Abstract

GlaxoSmithKline (NYSE: GSK) announced that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) recommended that CERVARIX=AE [Human papillomavirus bivalent (types 16 and 18) [...]

Published
2009

47. HPV vaccine update: Will there be more options for women and men?

Subjects
Merck & Company Inc., Papillomavirus infections -- Prevention, Cervical cancer -- Prevention, Cancer -- Care and treatment, Pharmaceutical industry, Cancer vaccines, Health, Cervarix (Vaccine)
Abstract

HPV vaccine update: Will there be more options for women and men? FDA committee gives nod to Cervarix use in females, Gardasil in males Get set for possible changes in [...]

Published
2009

48. Cervarix comes out ahead of Gardasil in trial

Subjects
Clinical trials, Health, Health care industry, Cervarix (Vaccine)
Abstract

The first head-to-head trial of the two cervical cancer vaccines has shown Cervarix, used in the national immunisation campaign, elicits a stronger immune response in women than Gardasil. The trial [...]

Published
2009

49. Cervarix, GSK's candidate vaccine for cervical cancer, demonstrated sustained efficacy

Subjects
Cervarix (Vaccine), Medical research, Medicine, Experimental, Papillomavirus infections -- Prevention, Cancer -- Care and treatment, Cervical cancer -- Prevention, Cancer vaccines, Pharmaceutical industry, Health, Prevention
Abstract

Cervarix, GlaxoSmithKline's (GSK) candidate vaccine for cervical cancer prevention, showed 100% efficacy over 4.5 years against precancerous lesions associated with human papillomavirus (HPV) types 16 and 18, the two most [...]

Published
2006

50. Cervarix, GSK's candidate vaccine for cervical cancer, demonstrates sustained efficacy

Subjects
Cervarix (Vaccine), Medical research, Medicine, Experimental, Papillomavirus infections -- Prevention, Cancer -- Care and treatment, Cervical cancer -- Prevention, Cancer vaccines, Pharmaceutical industry, Health, Prevention
Abstract

Cervarix, GlaxoSmithKline's (GSK) candidate vaccine for cervical cancer prevention, showed 100 percent efficacy over 4.5 years against precancerous lesions associated with human papillomavirus (HPV) types 16 and 18, the two [...]

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results